10Adson A W, Brown G E. The treatment of Raynaud' s disease by resection of the upperthoraei and lumbar sympathetic ganglia and thinks. Surg Cynecol Obstet, 1929,48:577.
8[2]Drott C. The history of cervicothoracic sympathectomy. Eur J Surg Suppl. 1994(572) :5 - 7.
9[3]Bardaxoglou E, Reigner B, Enon B, et al. Transthoracic endoscopy for upper thoracic chemical sympathectomy. Ann Vasc Surg 1992, 6(4) :390-2.
10[4]Adler OB, Engel A, Rosenberger A, et al. palmar hyperhidrosis CT guided chemical percutaneous thoracic sympathectomy. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, 1990, 153(4) :400 - 3.
5Tzilalis V,Panagiotopoulos N,Papatheodorou G,et al.Prevalence of Raynaud's phenomenon in young Greek males[J].Clin Rheumatol,2011,30(1):57-59.
6Reilly,Alice.Raynaud Phenomenon:Whether it's primary or secondary,there is no cure,but treatment can alleviate symptoms[J].American Journal of Nursing,August 2011,105(8):56-65.
7Thompson AE,Pope JE.Calcium channel blockers for primary Raynaud's phenomenon:a meta-analysis[J].Rheumatology,2011,44(2):145-150.
8Wise RA,Wigley FM,White B,et al.Efficacy and tolerability of a selective alpha -adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients:a single-center,double-blind,placebo-controlled,randomized cross over study[J].Arthritis Rheum,2008,50(12):3994-4001.
9Wood HM,Ernst ME.Ann Pharmacother.Renin-angiotensin system mediators and Raynaud's phenomenon[J].Epub 2009,40(11):1998-2002.
10Gliddon AE,Doré CJ,Black CM,et al.Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon:a multicenter,randomized,double-blind,placebo-controlled trial of the angiotensinconverting enzyme inhibitor quinapril[J].Arthritis Rheum,2011,56(11):3837-3846.
